[Posterior sagittal anorectoplasty (PSARP) in children with high anal atresia]

B Zupancić1, A Antabak, L Popović

  • 1Klinicki bolnicki centar Zagreb, Klinika za kirurgiju Medicinskog fakulteta Sveucilista u Zagrebu.

Lijecnicki Vjesnik
|August 8, 2009
PubMed

Insights

Anorectal anomalies, affecting 1 in 3000 infants, pose significant challenges. The Pena-de Vries method (PSARP) has improved fecal continence rates in children with high supralevator anomalies.

Area of Science:

  • Pediatric Surgery
  • Developmental Biology

Context:

  • Anorectal anomalies are a significant congenital condition affecting approximately 1 in 3000 infants.
  • High supralevator anorectal anomalies historically presented with high rates of fecal incontinence (50-80%) despite surgical efforts.
  • Advancements in surgical techniques aim to reconstruct pelvic anatomy and improve functional outcomes.

Purpose:

  • To evaluate the efficacy of the Pena-de Vries method (Posterior Sagittal Anorectoplasty - PSARP) in achieving fecal continence in children with high supralevator anorectal anomalies.
  • To assess the functional outcomes of PSARP in a cohort of pediatric patients, focusing on continence rates.

Summary:

  • The Pena-de Vries method (PSARP), introduced in 1982, utilizes electrical stimulation to precisely identify and reconstruct the anorectal sphincter complex.
  • This surgical approach involves mobilizing and modeling the rectum for insertion into the identified muscle-sphincter complex.
  • A ten-year study of 15 children (14 boys, 1 girl) who underwent PSARP, with a focus on those with rectourethral and rectovaginal fistulas and associated anomalies, demonstrated a 67% continence rate in children over 3 years old.

Impact:

  • The PSARP technique represents a significant advancement in the surgical management of high anorectal anomalies.
  • Improved surgical reconstruction has led to better functional outcomes, specifically enhancing fecal continence in affected children.
  • This study highlights the potential of PSARP to improve the quality of life for children born with complex anorectal malformations.